Potential of ADX-629 in COVID-19 lifts Aldeyra, up 14% premarket [Seeking Alpha]
Aldeyra Therapeutics, Inc. (ALDX)
Last aldeyra therapeutics, inc. earnings: 11/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.aldeyra.com/investor-relations
Company Research
Source: Seeking Alpha
Thinly traded nano cap Aldeyra Therapeutics (NASDAQ:ALDX14%In 85 healthy volunteers, orally administered ADX-629 was well-tolerated with no treatment-related adverse events observed with clinically relevant plasma concentrations. Reductions in pro-inflammatory RASP malondialdehyde was noted in treated participants.The companyplans to meetIt plans to test ADX-629 in Phase 2 studies in patients with respiratory and dermal conditions associated with elevated RASP levels.
Show less
Read more
Impact Snapshot
Event Time:
ALDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALDX alerts
High impacting Aldeyra Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ALDX
News
- Aldeyra Therapeutics: Reproxalap's March 2026 FDA Decision Is The Defining Catalyst [Seeking Alpha]Seeking Alpha
- Aldeyra Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist [Yahoo! Finance]Yahoo! Finance
- Aldeyra Therapeutics, Inc. (ALDX) Discusses PDUFA Target Action Date Extension for Reproxalap in Dry Eye Disease Transcript [Seeking Alpha]Seeking Alpha
- Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease [Yahoo! Finance]Yahoo! Finance
- Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye DiseaseBusiness Wire
ALDX
Earnings
- 11/5/25 - Beat
ALDX
Sec Filings
- 12/31/25 - Form 8-K
- 12/16/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- ALDX's page on the SEC website